Kolate AI
KolateAI is an AI-powered platform revolutionizing drug development by providing patient-level clinical events prediction and targeting. Their solution aims to accelerate pharmaceutical trials and real-world studies by addressing the broken drug development process, characterized by high failure rates and costs. KolateAI leverages its AI-driven Clinical Events Prediction Engine and Co-pilot to transform trials, enabling precise patient targeting, comparison of alternative therapies, and proactive study management. The platform integrates real-world data and proprietary data sources with unique modeling techniques to offer insights that lead to significant benefits, including increased revenue, profitability, and faster time-to-market. Their offerings include KolateAI Predict for patient-level outcome prediction, KolateAI Compare for therapy comparison, and KolateAI Co-pilot for interactive study management.
Kolate AI
KolateAI is an AI-powered platform revolutionizing drug development by providing patient-level clinical events prediction and targeting. Their solution aims to accelerate pharmaceutical trials and real-world studies by addressing the broken drug development process, characterized by high failure rates and costs. KolateAI leverages its AI-driven Clinical Events Prediction Engine and Co-pilot to transform trials, enabling precise patient targeting, comparison of alternative therapies, and proactive study management. The platform integrates real-world data and proprietary data sources with unique modeling techniques to offer insights that lead to significant benefits, including increased revenue, profitability, and faster time-to-market. Their offerings include KolateAI Predict for patient-level outcome prediction, KolateAI Compare for therapy comparison, and KolateAI Co-pilot for interactive study management.
TL;DR
What they do: AI platform for patient-level clinical events prediction, trial patient targeting, therapy comparison, and interactive study management
Founded: 2023
Stage / funding: Seed (Jan 2024), $150K
Headcount (reported): 3
Founder / CEO: Vinodh Balaraman
Company Overview
Problem Domain
High failure rates, long timelines, and cost inefficiencies in drug development and clinical trials.
Founded
2023
Industry
Biotechnology
Tech Stack
Funding Track Record
150000
Investor Signal
“Participation by startup accelerator (Entrepreneurs Roundtable Accelerator); resident relationship with Johnson & Johnson Innovation JLABS”